Roche & UBS
2 shared events · Importance 3 · Last updated Jun 14, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Roche: Roche agreed to pay Nurix Therapeutics up to $2.3 billion for rights to an experimental blood-cancer drug.
UBS: Analysts at UBS raised their 12-month price target for Micron Technology, contributing to the positive sentiment around the stock.
May 20, 2026 · 72 articles
Domestic
Roche: Roche>>> posted modest gains, contributing to the overall positive sentiment in the Switzerland>>> market.
UBS: UBS>>> gained nearly 1%, contributing to the positive close of the Switzerland>>> market.
May 21, 2026 · 8 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Roche and UBS interact across events, view sentiment trends, and discover connected entities.
Open Dashboard